Form4insider filings, from the source

SEC Form 4 · accession 0001736749-18-000011

Zivo Bioscience, Inc. · ZIVO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark E Strome
10% Owner
Period of report
Nov 20, 2017
Accepted (ET)
Oct 24, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Purchase WarrantF1,F2,F3,F4$0.10Nov 21, 2017P666,667ANov 21, 2017Nov 20, 2022Common Stock666,667666,667I
Common Stock Purchase WarrantF5,F3,F4$0.10Nov 21, 2017P333,333ANov 21, 2017Nov 20, 2022Common Stock333,3331,000,000I
Convertible DebtF6,F7,F3,F4$0.10Jun 28, 2018P—AJun 28, 2018Apr 1, 2019Common Stock6,911,870—I
Common Stock Purchase WarrantF8,F3,F4$0.10Jun 7, 2018P16,000,000AJun 7, 2018Jun 1, 2023Common Stock16,000,00016,000,000I
Common Stock Purchase WarrantF8,F3,F4$0.10Jun 7, 2018P9,000,000AJun 7, 2018Jun 1, 2023Common Stock9,000,0009,000,000I

Explanation of responses